feed,title,long_url,short_url
Benzinga,BeiGene's Brukinsa US Application For Expanded Use Under FDA Review,https://benzinga.com/general/biotech/21/05/21192862/beigenes-brukinsa-us-application-for-expanded-use-under-fda-review,https://j.mp/2Rw9WpF
Benzinga,Myovant Stock Is Trading Lower After FDA Slapped Clinical Hold On Relugolix Combo Study,https://benzinga.com/general/biotech/21/05/21192401/myovant-stock-is-trading-lower-after-fda-slapped-clinical-hold-on-relugolix-combo-study,https://j.mp/3ywdYiP
